Start Thinking About Weed Control Now: Plan Ahead for Improved Hay Quality and More Profit Next Spring and Into Summer |
|
Sponsored content created by Jason Belcher, Stewardship and Development Manager - Eastern U.S., Bayer Environmental ScienceThe key for growers to maximize desirable grasses and profit is to plan ahead and be proactive about protecting their hayfields. This change of mindset can deliver results and peace of mind throughout the season.* When it comes to controlling spring and summer annual weeds, Bayer Range & Pasture recommends an application of Rezilon® herbicide in January while following label directions carefully. There are several reasons why an early application of Rezilon delivers unrivaled control of annual weeds:
Rezilon controls more than 60 broadleaf and annual grass weeds, including species that have developed herbicide resistance, such as ryegrass. Using Rezilon herbicide as directed can lead to higher-quality hay on the first harvest, and it also reduces the time and money hay growers would need to spend on additional herbicide applications. If it seems too early to start planning for spring and results, it is actually the right time. Bayer Range & Pasture encourages hay growers in the south who are struggling to control annual weeds to visit Rezilon.com to learn more about solutions and contact a representative. *Four to six months of anticipated control from a single application. Company description: Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com. Legals: |